CAR-T,

Niloufar Mohammadkhani1,2, Saber Ebrahimi3,4, Marzieh Hesam Mohammadi1,2

  • 1Department of Medicine I, Medical Center-University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Cancer gene therapy
|March 16, 2026
PubMed
概括

研究了增强仿真抗原受体 (CAR) T细胞持久性的策略,平衡抗瘤活性与潜在的毒性. 新兴的"现成"CAR-T疗法可能会减少对延长CAR-T细胞存活的需求.